Pediatric Informatics: Computer Applications in Child Health (Health ...

27 Dispensing: Pharmacy Information Systems 355
3. Chaffee BW, Bonasso J. Strategies for pharmacy integration and pharmacy information
system interfaces, Part 2: scope of work and technical aspects of interfaces. Am J Health Syst
Pharm. 2004;61(5):506–514.
4. Chaffee BW, Townsend KA, Benner T, de Leon RF. Pharmacy database for tracking drug
costs and utilization. Am J Health Syst Pharm. 2000;57(7):669–676.
5. Osheroff JA, Teich JM, Middleton BF, Steen, EB, Wright A, Detmer DE. A Roadmap for
National Action on Clinical Decision Support. American Medical Informatics Association;
2006. Available at: http://www.amia.org/inside/initiatives/cds/. Accessed December 21,
2008.
6. Liem RI, Higman MA, Chen AR, Arceci RJ. Misinterpretation of a Calvert-derived
formula leading to carboplatin overdose in two children. J Pediatr Hematol Oncol.
2003;25(10):818–821.
7. van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized
physician order entry. J Am Med Inform Assoc. 2005;13(2):138–147. Available at: http://www.
jamia.org/cgi/content/abstract/13/2/138. Accessed December 21, 2008.
8. Kuperman GJ, Gandhi TK, Bates DW. Effective drug-allergy checking: methodological and
operational issues. J Biomed Inform. 2003;36(1–2):70–79.
9. Pham PA. Drug-drug interaction programs in clinical practice. Clin Pharmacol Ther.
2008;83(3):396–398.
10. Alkema GE, Wilber KH, Simmons WJ, Enguidanos SM, Frey D. Prevalence of potential
medication problems among dually eligible older adults in Medicaid waiver services. Ann
Pharmacother. 2007;41(12):1971–1978.
11. Koren G, Schechter T. Cancer chemotherapy in young children: challenges and solutions.
Pediatr Blood Cancer. 2007;49(7 Suppl):1091–1092.
12. Green DM, Grigoriev YA, Nan B, et al. Congestive heart failure after treatment for
Wilms’ tumor: a report from the National Wilms’ Tumor Study group. J Clin Oncol.
2001;19(7):1926–1934.
13. Hennessy SC. Developing standard concentrations in the neonatal intensive care unit. Am J
Health Syst Pharm. 2007;64(1):28–30.
14. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and
adverse drug events in the intensive care unit. JAMA. 1999;282(3):267–270.
15. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams
reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med.
2003;163(17):2014–2018.
16. Wang JK, Herzog NS, Kaushal R, Park C, Mochizuki C, Weingarten SR. Prevention of
pediatric medication errors by hospital pharmacists and the potential benefit of computerized
physician order entry. Pediatrics. 2007;119(1):e77–e85.
17. Veltri MA, Ascenzi J, Clark JS, et al. Successful Elimination of the “Rule of Six”
in an Academic Children’s Hospital Through a Medication-Use-System Redesign and
Standardization of Continuous Infusions. American Society of Health-Systems Pharmacists
2006 Mid Year Meeting [Poster]; 2006. Available at: http://www.ashpadvantage.com/
bestpractices/2006_papers/veltri.htm. Accessed December 21, 2008.
18. Lehmann CU, Kim GR, Gujral R, Veltri MA, Clark JS, Miller MR. Decreasing errors in pediatric
continuous intravenous infusions. Pediatr Crit Care Med. 2006;7(3):225–230.
19. Joint Commission. Transition to standardized drug concentrations by the end of 2008.
Jt Comm Perspect. 2005;25(4):3–5.